Diseases & Disorders
(G19)
IRS Verified
DX Registered
990 on File
CURE JM FOUNDATION
Financial strength (30%)
89/100
Reliability (20%)
55/100
Effectiveness (25%)
81/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
Cure JM is the global leader in juvenile myositis (JM) research. We are paving the way to better treatments for JM while improving the lives of families affected by the disease.
Financial Overview — FY 2025
N/A
Total Revenue
N/A
Total Expenses
N/A
Net Assets
N/A
Employees
Program Expense Ratio
N/A
Fundraising Efficiency
0.0%
Operating Reserve
N/A
Liability-to-Asset
0.0%
Revenue Diversification
N/A
Compared with Peers
FY 2025
Compared with 264 similar organizations
(United States, Diseases & Disorders, $1M–$10M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
0.0% | 112.2% |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 12.5% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
-100.0% | 7.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-100.0% | 5.7% |
P10P90
|
Impact
1 program| Outcome / Program | People Served | Cost / Service | # Completed | Duration |
|---|---|---|---|---|
| Improved health and quality of life for children and young adults living with juvenile myositis thro | 3,000 | $688.00 | — | Per Day |
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | N/A | N/A | N/A | — | — |
| 2024 | $2.3M | $2.1M | N/A | — | 8 |
| 2023 | $2.2M | $2.1M | $2.3M | 83.8% | 8 |
| 2022 | $1.8M | $1.8M | $2.1M | 54.8% | 10 |
| 2021 | $2.2M | $2.0M | N/A | — | 6 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.